Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

Biomaterials
A ZaghmiM A Gauthier

Abstract

The parenteral administration of protein therapeutics is increasingly gaining importance for the treatment of human diseases. However, the presence of practically impermeable blood-brain barriers greatly restricts access of such pharmaceutics to the brain. Treating brain disorders with proteins thus remains a great challenge, and the slow clinical translation of these therapeutics may be largely ascribed to the lack of appropriate brain delivery system. Exploring new approaches to deliver proteins to the brain by circumventing physiological barriers is thus of great interest. Moreover, parallel advances in the molecular neurosciences are important for better characterizing blood-brain interfaces, particularly under different pathological conditions (e.g., stroke, multiple sclerosis, Parkinson's disease, and Alzheimer's disease). This review presents the current state of knowledge of the structure and the function of the main physiological barriers of the brain, the mechanisms of transport across these interfaces, as well as alterations to these concomitant with brain disorders. Further, the different strategies to promote protein delivery into the brain are presented, including the use of molecular Trojan horses, the formulatio...Continue Reading

References

Dec 6, 1979·Nature·M van Houten, B I Posner
Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Sep 1, 1975·Biotechnology and Bioengineering·G Vegarud, T B Christnsen
Jan 1, 1975·Acta Chemica Scandinavica. Series B: Organic Chemistry and Biochemistry·G Vegarud, T B Christensen
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J F Poduslo, G L Curran
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·K YoshidaE F Ellis
May 1, 1991·Stroke; a Journal of Cerebral Circulation·S E HaunR J Traystman
Jan 1, 1990·Annual Review of Physiology·W Almers
Sep 1, 1990·Stroke; a Journal of Cerebral Circulation·S ImaizumiP H Chan
Oct 1, 1989·Protein Engineering·A V Kabanov Alakhov VYu
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D TrigueroW M Pardridge
Oct 1, 1985·Journal of Neurochemistry·W M PardridgeJ Eisenberg
Jul 15, 1987·Biochemical and Biophysical Research Communications·W M PardridgeJ B Eisenberg
Mar 1, 1986·The Biochemical Journal·A E Pegg
Oct 1, 1988·Radiology·R I GrossmanF Gonzalez-Scarano
Mar 15, 1974·Biochemical and Biophysical Research Communications·S HickmanE F Neufeld
Jan 1, 1974·Methods in Enzymology·W E PricerA G Morell
Oct 1, 1980·The Journal of Pharmacy and Pharmacology·T J PostmesJ Coenegracht
Apr 1, 1984·The Journal of Clinical Investigation·V M VehaskariA M Robson
Jan 1, 1982·Annual Review of Biochemistry·G Ashwell, J Harford
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S L MorrisonV T Oi

❮ Previous
Next ❯

Citations

Nov 23, 2021·Nanomedicine·Anisha A D'SouzaMansoor M Amiji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.